Clinical and Hemodynamic Responses to Imatinib in Pulmonary Veno-Occlusive Disease/Pulmonary Capillary Hemangiomatosis: A Retrospective Pilot Study of Five Cases and Review of the Literature.
Junichi NakamuraIchizo TsujinoHideki ShimaToshitaka NakayaAyako SugimotoTakahiro SatoTaku WatanabeHiroshi OhiraMasaru SuzukiSatonori TsunetaRyo HisadaMasaru KatoSatoshi KonnoPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2023)
This study indicated that imatinib improves the clinical condition, including pulmonary hemodynamics, of some patients with PVOD/PCH. In addition, patients with a certain high-resolution computed tomography pattern or PCH-dominant vasculopathy may respond favorably to imatinib.